<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-1134</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>ИДЕАЛЬНАЯ ДОЗА АЦЕТИЛСАЛИЦИЛОВОЙ КИСЛОТЫ ДЛЯ ПРИМЕНЕНИЯ В КАРДИОЛОГИИ – ПОИСК ЗАВЕРШЕН?</article-title><trans-title-group xml:lang="en"><trans-title>IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аверков</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Averkov</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">oleg.averkov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГКБ №15 им. О.М.Филатова, Москва</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2011</year></pub-date><volume>0</volume><issue>4</issue><fpage>119</fpage><lpage>127</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аверков О.В., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Аверков О.В.</copyright-holder><copyright-holder xml:lang="en">Averkov O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/1134">https://russjcardiol.elpub.ru/jour/article/view/1134</self-uri><abstract><p>.</p></abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Buerke M, Pittroff W, Meyer J, et al. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses// AmHeart J. 1995;130:465-472.</mixed-citation><mixed-citation xml:lang="en">Buerke M, Pittroff W, Meyer J, et al. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses// AmHeart J. 1995;130:465-472.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects//J Clin Invest. 1982;69:1366-1372.</mixed-citation><mixed-citation xml:lang="en">Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects//J Clin Invest. 1982;69:1366-1372.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dabaghi SF, Kamat SG, Payne J, et al. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects//Am J Cardiol. 1994;74:720-723.</mixed-citation><mixed-citation xml:lang="en">Dabaghi SF, Kamat SG, Payne J, et al. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects//Am J Cardiol. 1994;74:720-723.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition//Circulation. 1985;72:177-184</mixed-citation><mixed-citation xml:lang="en">Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition//Circulation. 1985;72:177-184</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Montalescot G, Maclouf J, Drobinski G, et al. Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin// J Am Coll Cardiol. 1994;24:33-38.</mixed-citation><mixed-citation xml:lang="en">Montalescot G, Maclouf J, Drobinski G, et al. Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin// J Am Coll Cardiol. 1994;24:33-38.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Montalescot G, Drobinski G, Maclouf J, et al. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris// Circulation. 1991;84:2054-2062.</mixed-citation><mixed-citation xml:lang="en">Montalescot G, Drobinski G, Maclouf J, et al. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris// Circulation. 1991;84:2054-2062.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ridker PM, Hennekens CH, Tofler GH, et al. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebocontrolled trial of regular and enteric coated formulations in men and women//J Cardiovasc Risk. 1996; 3:209-212.</mixed-citation><mixed-citation xml:lang="en">Ridker PM, Hennekens CH, Tofler GH, et al. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebocontrolled trial of regular and enteric coated formulations in men and women//J Cardiovasc Risk. 1996; 3:209-212.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gurbel P.A, Bliden K.P, DiChiara J. et al. Evaluation of Dose-related effects of aspirin on platelet function. Results from the Aspirin[Induced Platelet Effect (ASPECT) Study//Circulation 2007; 115: 3156-3164</mixed-citation><mixed-citation xml:lang="en">Gurbel P.A, Bliden K.P, DiChiara J. et al. Evaluation of Dose-related effects of aspirin on platelet function. Results from the Aspirin[Induced Platelet Effect (ASPECT) Study//Circulation 2007; 115: 3156-3164</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Farrell B, Godwin J, Richards S, et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results//J Neurol Neurosurg Psychiatry. 1991;54:1044 –1054.</mixed-citation><mixed-citation xml:lang="en">Farrell B, Godwin J, Richards S, et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results//J Neurol Neurosurg Psychiatry. 1991;54:1044 –1054.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke//N Engl J Med. 1991;325:1261– 1266.</mixed-citation><mixed-citation xml:lang="en">The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke//N Engl J Med. 1991;325:1261– 1266.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor DW, Barnett HJ, Haynes RB et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial//ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999;353:2179–2184.</mixed-citation><mixed-citation xml:lang="en">Taylor DW, Barnett HJ, Haynes RB et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial//ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999;353:2179–2184.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lee TK, Lien IN, Ryu SJ, et al. Secondary prevention of ischemic stroke with low dose acetylsalicylic acid// J Formos Med Assoc. 1990;89:635-644.</mixed-citation><mixed-citation xml:lang="en">Lee TK, Lien IN, Ryu SJ, et al. Secondary prevention of ischemic stroke with low dose acetylsalicylic acid// J Formos Med Assoc. 1990;89:635-644.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman W, Forster W. Two year Cottbus reinfarction study with 30 mg aspirin per day // Prostaglandins Leukot Essent Fatty Acids. 1991;44:159-169.</mixed-citation><mixed-citation xml:lang="en">Hoffman W, Forster W. Two year Cottbus reinfarction study with 30 mg aspirin per day // Prostaglandins Leukot Essent Fatty Acids. 1991;44:159-169.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connor CM, Meese RB, McNulty S, et al; DUCCS-II Investigators. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction//Am J Cardiol. 1996;77:791-797.</mixed-citation><mixed-citation xml:lang="en">O’Connor CM, Meese RB, McNulty S, et al; DUCCS-II Investigators. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction//Am J Cardiol. 1996;77:791-797.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Minar E, Ahmadi A, Koppensteiner R, et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty//Circulation. 1995;91:2167-2173.</mixed-citation><mixed-citation xml:lang="en">Minar E, Ahmadi A, Koppensteiner R, et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty//Circulation. 1995;91:2167-2173.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">The CURRENT-OASIS Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes//N Engl J Med 2010; 363:930-942.</mixed-citation><mixed-citation xml:lang="en">The CURRENT-OASIS Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes//N Engl J Med 2010; 363:930-942.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mehta S., Bassnd J.-P., Chrolavicus S. et al on behalf of the CURRENT-OASIS7 committee. Design and rationale of CURRENT-OASIS7: A randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST elevation acute coronary syndromes managed with an early invasive strategy // Am Heart J 2008; 156: 1080-1088</mixed-citation><mixed-citation xml:lang="en">Mehta S., Bassnd J.-P., Chrolavicus S. et al on behalf of the CURRENT-OASIS7 committee. Design and rationale of CURRENT-OASIS7: A randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST elevation acute coronary syndromes managed with an early invasive strategy // Am Heart J 2008; 156: 1080-1088</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">С остальными литературными источниками (18-33) можно ознакомиться – cardio.nauka@yandex.ru</mixed-citation><mixed-citation xml:lang="en">С остальными литературными источниками (18-33) можно ознакомиться – cardio.nauka@yandex.ru</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
